Tag: evaluation

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes 
• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced
• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist

New York City, NY, June 05, 2026 (GLOBE NEWSWIRE) -- As warmer weather returns, many homeowners start noticing the same thing around their property. Surfaces that once looked clean and inviting are now covered with grime, algae stains, and months of built-up dirt. Driveways lose their brightness, patios become slippery and discolored, and wooden decks begin to look worn long before their time.

New end-to-end compliance initiative supports providers preparing for the Federal Government’s expanded NDIS registration reforms ahead of the July 2027 Mandatory Registration deadline

SHANGHAI, June 05, 2026 (GLOBE NEWSWIRE) -- Sigenergy, a global pioneer in "AI + Energy Storage" technology, accelerated its international growth at SNEC 2026 by securing a TÜV SÜD Bankability Due Diligence Report for its SigenTerra utility-scale storage system. This independent validation confirms SigenTerra’s exceptional technical maturity, safety, and long-term investment value, paving the way for seamless project financing worldwide.